Celgene Associate Director Global Medical Affairs Multiple Myeloma in Summit, New Jersey

Description

Celgene is a global biopharmaceutical company leading the way in medical innovation to help patients live longer, better lives. Our purpose as a company is to discover and develop therapies that will change the course of human health. We value our passion for patients, ​quest for innovation, spirit of independence and love of challenge. With a presence in more than 70 countries, and growing - we look for talented people to grow our business, advance our science and contribute to our unique culture.

The Associate Director will report to the Global Medical Affairs (GMA) Disease Lead for Multiple Myeloma. He/she will be head office based and will provide scientific/medical leadership and support for compounds in various stages of clinical development, as well as approved products in that therapeutic area. This individual will support the design and implementation of an integrated medical plan within global for their area, under the direction of the GMA Disease Lead, and in coordination with an overarching Disease Strategy Team plan for Multiple Myeloma. They may support the evaluation of investigator-initiated trials in their area. He/she will represent the GMA as needed on behalf of the GMA Disease Lead, serving as a therapeutic area expert in strategic and tactical discussions and presentations with internal colleagues as well as external experts and investigators.

Responsibilities will include, but are not limited to, the following:

  1. May represent GMA on behalf of the Disease Lead as a therapeutic area expert in both internal and external venues including Global Project Team, clinical sub-teams, and advisory boards / steering committees2. Collaborate with Medical Affairs colleagues to guide and execute therapeutic area strategy and tactics with appropriate use of resources and performance to goals3. Support/may lead Medical Affairs cross-functional working groups4. Will represent company at professional meetings, congresses, and local symposia5. May provide assistance in the planning and execution of Medical Affairs Sponsored Trials, within appropriate standards for compliance, quality, timeliness, and budget. Support the Disease Leads in the design, execution, and evaluation of clinical trials according to strategy and good clinical practice.6. High quality scientific/clinical input and review of: Disease strategy/plans, abstracts, posters, slides, manuscripts in disease area, educational materials in disease area including slides, webcasts, etc., LOIs/ IIT protocols in disease area, steering committee and advisory board meeting objectives, materials, CTB, booth panels, Med info letters, CDPs, Commercial Brand plans, Integrated Disease Plans, Open data questions (ODQs) in disease area, Scientific educational grant requests and patient advocacy grant requests7. Assist with Global Disease Strategy and Plans8. Track priority Medical Affairs tactics and performance to goals/budget9. Perform, as needed, research and analytics and provide recommendations to support quality medical decisions regarding clinical research, consultancy, and internal planning.10. Partner with Corporate Medical Affairs in developing publication strategy, gap analysis, internal medical education training and scientific statement 11. Assist with scientific searches, data summaries, preparation for site visits/corporate visits/payor presentations12. Interaction with key stakeholders, as a therapeutic area and strategic expert:

The ideal candidate will have the following mix of professional and personal characteristics:

  • Advanced degree (M.D., PhD. or Master’s) in health-related field.

  • Expertise in hematology/oncology including relevant content area, with 3+ years industry experience

  • Expertise in the conduct of clinical trials in hematology/oncology.

  • Excellent analytical skills and solid experience in translating medical/clinical information into medical affairs strategies.

  • Proficiency in critical data review and interpretation.

  • Product lifecycle management experience preferred.

  • Good understanding of Medical Affairs and the compliance issues concerning MA function.

  • Influence management of successful cross-functional and multi-disciplinary teams.

  • Excellent communication and organization skills. Excellent presentation skills, including presenting to large groups, facilitation of interactive discussions, and 1:1 discussions with experts in the therapeutic area.

  • Demonstrated customer focus orientation & credibility with customers.

  • Knowledge/application of data sources, reports and tools for the creation of solid plans.

  • Possess strong business acumen and financial skills. Budget experience.

  • Regular travel will be required.

#LI-POST

Celgene is committed to equal opportunity in the terms and conditions of employment for all employees and job applicants without regard to race, color, religion, sex, sexual orientation, age, gender identity or gender expression, national origin, disability or veteran status. Celgene complies with all applicable national, state and local laws governing nondiscrimination in employment as well as employment eligibility verification requirements of the Immigration and Nationality Act. All applicants must have authorization to work for Celgene in the U.S.COMMITTED TO IMPROVING THE LIVES OF PATIENTS WORLDWIDE

At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients. Our vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions.

“At Celgene, we seek to deliver truly innovative and life-changing drugs for our patients.”

There are more than 300 clinical trials at major medical centers using compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), triple-negative breast cancer and pancreatic cancer. As committed as we are to clinical accomplishment, we are equally committed to patient support, which is a guiding principle at Celgene. We believe all who can benefit from our discoveries should have the opportunity to do so. Celgene puts patients first with industry-leading programs that provide information, support and access to our innovative therapies.